Thursday, 30 June, 2022
HomeIndiaIndia likely to join WHO's Covid-19 treatment 'solidarity trial'

India likely to join WHO’s Covid-19 treatment ‘solidarity trial’

The WHO is starting a multi-country clinical study for the potential treatment of Covid-19 as part of a rapid global search for drugs to treat Covid-19.

Text Size:

New Delhi: India is likely to participate in the World Health Organisation’s (WHO) ‘solidarity trial’ for a potential treatment for COVID-19.

Addressing a press conference here, Dr R Ganga Ketkar of Indian Council of Medical Research (ICMR) said: “We are likely to start our participation soon in solidarity trial that the WHO is starting.” “Earlier we did not do it because our numbers were so small that our contribution would have looked minuscule,” added Ketkar.

The WHO is starting a multi-country clinical study for the potential treatment of COVID-19, part of a rapid global search for drugs to treat COVID-19.
A total of 724 confirmed cases of COVID-19 have been reported in India, the Ministry of Health and Family Welfare said on Friday.

“Till now 724 COVID-19 cases have been confirmed and total deaths stand at 17. In the last 24 hours, 75 new positive cases and 4 deaths have been reported,” said Lav Aggarwal, Joint Secretary, Union Health Ministry.


Also read: Coronavirus: Latest updates on cases in India, all you need to know about COVID-19


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Most Popular

×